SenesTech, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 0.09%74.741.0%$1810.19m
AMGNAmgen, Inc. 4.28%217.721.3%$936.80m
REGNRegeneron Pharmaceuticals, Inc. 1.35%508.292.6%$843.84m
BIIBBiogen, Inc. 4.81%315.701.5%$805.53m
VRTXVertex Pharmaceuticals, Inc. 0.25%248.281.9%$645.83m
MRNAModerna, Inc. 1.22%32.410.0%$525.08m
ILMNIllumina, Inc. -0.62%278.913.5%$491.27m
ALXNAlexion Pharmaceuticals, Inc. 3.84%98.362.0%$311.27m
AAgilent Technologies, Inc. 2.34%75.761.6%$232.25m
INCYIncyte Corp. 0.97%87.502.5%$220.34m
EXASEXACT Sciences Corp. 4.36%65.3321.0%$186.45m
SGENSeattle Genetics, Inc. -1.78%119.706.1%$161.67m
BMRNBioMarin Pharmaceutical, Inc. -0.34%79.564.3%$153.40m
NVAXNovavax, Inc. 15.30%17.18114.7%$131.39m
IMMUImmunomedics, Inc. -2.27%18.4811.9%$118.05m

Company Profile

SenesTech, Inc. engages in the development and commercialization of a proprietary technology for the management of animal pest populations, primarily rat populations through fertility control. It offers its ContraPest product to residential, and commercial sector such as animal, structural, and food markets. The company was founded by Loretta P. Mayer and Cheryl A. Dyer in July 2004 and is headquartered in Phoenix, AZ.